Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

BIOC-11 is under development for the treatment of bronchiectasis caused by Pseudomonas aeruginosa and cystic fibrosis. This candidate is formulated as an isotonic, buffered aqueous solution for oral ...

INR:5815. sikkim state lottery live draw New drug for cystic fibrosis! Kalydeco approved by the EU for use in infants aged 4-6 months The ranking o ...

crazy time result Science: Revealing the structure of hinge-like protein provides new ideas for treating cystic fibrosis Why did China's first province-wide prescription circulation fall into the ...

This year marked the 22 nd anniversary of Carols by Candlelight, an annual event held in memory of Alice Martineau, a ...